Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Karen E Hansen"'
Publikováno v:
JBMR Plus, Vol 3, Iss 7, Pp n/a-n/a (2019)
Abstract Hypercalcemia most often results from primary hyperparathyroidism and malignancy. Adynamic bone disease (ABD) is a form of renal osteodystrophy characterized by reduced bone turnover, which can limit the ability of bone to release or store c
Externí odkaz:
https://doaj.org/article/753e29eb1ee0486b9f9023ed32160ae7
Autor:
Haukur T. Gudmundsson, Karen E. Hansen, Bjarni V. Halldorsson, Bjorn R. Ludviksson, Bjorn Gudbjornsson
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Although osteoporosis is an easily diagnosed and treatable condition, many individuals remain untreated. Clinical decision support systems might increase appropriate treatment of osteoporosis. We designed the Osteoporosis Advisor
Externí odkaz:
https://doaj.org/article/a86d479b04b94aa18489a55d900c2b80
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 15, Iss , Pp 30-35 (2018)
Background: Low bone mineral density (BMD) and subsequent skeletal fragility have emerged as a long-term complication of phenylketonuria (PKU). Objective: To determine if there are differences in BMD and body composition between male and female parti
Externí odkaz:
https://doaj.org/article/aba741ad207e40f2a24c1c1c339808d8
Publikováno v:
The Journal of Nutrition.
Autor:
Julia Amariti, Brandon D. McGuire, Anna R. Ogilvie, Kristen M. Beavers, Karen E. Hansen, Yvette Schlussel, Michael P. Walkup, Sue A. Shapses
Publikováno v:
Calcified Tissue International. 111:137-144
Obesity is a risk factor for chronic diseases and moderate weight loss is generally recommended. Energy restriction results in the loss of hip bone mineral density (BMD) in older adults, but there is no consistent decline at the lumbar spine (LS), po
Autor:
Bridget M. Stroup, Emily A. Sawin, Sangita G. Murali, Neil Binkley, Karen E. Hansen, Denise M. Ney
Publikováno v:
Journal of Nutrition and Metabolism, Vol 2017 (2017)
Background. Skeletal fragility is a complication of phenylketonuria (PKU). A diet containing amino acids compared with glycomacropeptide reduces bone size and strength in mice. Objective. We tested the hypothesis that amino acid medical foods (AA-MF)
Externí odkaz:
https://doaj.org/article/5bb5275fdfc048329cbb4911901c30e5
Autor:
Zeina A Yanbeiy, Karen E. Hansen
Publikováno v:
Drug Design, Development and Therapy. 13:2843-2852
Objective Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis. In May 2018, denosumab was approved for the treatment of GIOP in men and women at high risk of fracture. We undertook a systematic review and meta
The −839(A/C) Polymorphism in the ECE1 Isoform b Promoter Associates With Osteoporosis and Fractures
Autor:
Tonia C. Carter, Michael G. Johnson, Robert D. Blank, Karen E. Hansen, Nicholas S. Keuler, John E. Mayer
Publikováno v:
Journal of the Endocrine Society. 3:2041-2050
Context We previously found that variation in a quantitative trait locus, including the gene-encoding endothelin-converting enzyme 1 (Ece1), accounted for 40% of the variance in bone biomechanics and bone mineral density (BMD) in an intercross of rec
Publikováno v:
Osteoporosis International. 30:2019-2025
Doctors do not know whether treatment of high parathyroid hormone levels is linked to better outcomes in their patients with kidney disease. In this study, lower parathyroid hormone levels at baseline were linked to lower risk of fracture, vascular e
Autor:
Shivani Garg, Michael G. Semanik, Yabing Huang, Christie M. Bartels, Weixiong Zhong, Sarah E. Panzer, Karen E. Hansen, Maureen A. Smith
Publikováno v:
Arthritis Care Res (Hoboken)
Objective Cardiovascular disease (CVD) is accelerated in patients with systemic lupus erythematosus and lupus nephritis (LN). Despite the literature suggesting that renal arteriosclerosis predicts CVD in other glomerulonephritis diseases, arterioscle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::015bab422c462a2d7a4f72d5f9b72f68
https://europepmc.org/articles/PMC8162670/
https://europepmc.org/articles/PMC8162670/